Promoter Methylation status of HIN-1 associated with outcomes of ovarian clear cell adenocarcinoma

<p>Abstract</p> <p>Background</p> <p>This study is to analyze promoter methylation of various tumor suppressor genes in different types of ovarian carcinoma and to identify potential therapeutic targets of ovarian clear cell adenocarcinoma (OCCA).</p> <p>Mat...

Full description

Bibliographic Details
Main Authors: Ho Chih-Ming, Huang Chi-Jung, Huang Chia-Yen, Wu Yih-Yiing, Chang Shwu-Fen, Cheng Wen-Fang
Format: Article
Language:English
Published: BMC 2012-08-01
Series:Molecular Cancer
Subjects:
Online Access:http://www.molecular-cancer.com/content/11/1/53
id doaj-4879115ece0c4af88c4ca3768268a476
record_format Article
spelling doaj-4879115ece0c4af88c4ca3768268a4762020-11-25T00:42:04ZengBMCMolecular Cancer1476-45982012-08-011115310.1186/1476-4598-11-53Promoter Methylation status of HIN-1 associated with outcomes of ovarian clear cell adenocarcinomaHo Chih-MingHuang Chi-JungHuang Chia-YenWu Yih-YiingChang Shwu-FenCheng Wen-Fang<p>Abstract</p> <p>Background</p> <p>This study is to analyze promoter methylation of various tumor suppressor genes in different types of ovarian carcinoma and to identify potential therapeutic targets of ovarian clear cell adenocarcinoma (OCCA).</p> <p>Materials and methods</p> <p>The promoter methylation statuses of 40 genes in primary ovarian carcinomas including 47 clear- and 63 non-clear-cell type tissues, 6 OCCA cell lines, 29 benign ovarian endometriotic cysts, and 31 normal controls were analyzed by methylation-specific multiplex ligation-dependent probe amplification (MS-MLPA). The MS-MLPA results were correlated with clinicopathological features and outcomes of 47 OCCA patients. Functions of the target genes were further explored by Western Blot Analysis, apoptosis assay, and caspase-3/7 activity analysis.</p> <p>Results</p> <p>Frequencies of methylated RASSF1A, CDH13, CACNA1A, HIN-1, and sFRP5 genes in OCCA tissues were significantly higher than those in non-OCCA cancerous tissues and benign endometriotic cysts<b>.</b> The expected OS for patients with methylated promoters of HIN-1 was significantly worse than those for patients without methylated HIN-1 (30% vs. 62%, <it>p</it> = 0.002). The HIN-1 gene was over-expressed in ES2 cells, a significant reduction in cell growth and induction of apoptosis, and increasing paclitaxel sensitivity by reducing phosphorylation of Akt were observed.</p> <p>Conclusions</p> <p>Methylation of HIN-1 promoter is a novel epigenetic biomarker associated with poor outcomes in OCCA patients. Ectopic expression of the HIN-1 gene increased paclitaxel sensitivity which is partly through Akt pathway.</p> http://www.molecular-cancer.com/content/11/1/53Ovarian clear cell adenocarcinomaMethylation-specific multiplex ligation-dependent probe amplificationHIN-1CACNA1A
collection DOAJ
language English
format Article
sources DOAJ
author Ho Chih-Ming
Huang Chi-Jung
Huang Chia-Yen
Wu Yih-Yiing
Chang Shwu-Fen
Cheng Wen-Fang
spellingShingle Ho Chih-Ming
Huang Chi-Jung
Huang Chia-Yen
Wu Yih-Yiing
Chang Shwu-Fen
Cheng Wen-Fang
Promoter Methylation status of HIN-1 associated with outcomes of ovarian clear cell adenocarcinoma
Molecular Cancer
Ovarian clear cell adenocarcinoma
Methylation-specific multiplex ligation-dependent probe amplification
HIN-1
CACNA1A
author_facet Ho Chih-Ming
Huang Chi-Jung
Huang Chia-Yen
Wu Yih-Yiing
Chang Shwu-Fen
Cheng Wen-Fang
author_sort Ho Chih-Ming
title Promoter Methylation status of HIN-1 associated with outcomes of ovarian clear cell adenocarcinoma
title_short Promoter Methylation status of HIN-1 associated with outcomes of ovarian clear cell adenocarcinoma
title_full Promoter Methylation status of HIN-1 associated with outcomes of ovarian clear cell adenocarcinoma
title_fullStr Promoter Methylation status of HIN-1 associated with outcomes of ovarian clear cell adenocarcinoma
title_full_unstemmed Promoter Methylation status of HIN-1 associated with outcomes of ovarian clear cell adenocarcinoma
title_sort promoter methylation status of hin-1 associated with outcomes of ovarian clear cell adenocarcinoma
publisher BMC
series Molecular Cancer
issn 1476-4598
publishDate 2012-08-01
description <p>Abstract</p> <p>Background</p> <p>This study is to analyze promoter methylation of various tumor suppressor genes in different types of ovarian carcinoma and to identify potential therapeutic targets of ovarian clear cell adenocarcinoma (OCCA).</p> <p>Materials and methods</p> <p>The promoter methylation statuses of 40 genes in primary ovarian carcinomas including 47 clear- and 63 non-clear-cell type tissues, 6 OCCA cell lines, 29 benign ovarian endometriotic cysts, and 31 normal controls were analyzed by methylation-specific multiplex ligation-dependent probe amplification (MS-MLPA). The MS-MLPA results were correlated with clinicopathological features and outcomes of 47 OCCA patients. Functions of the target genes were further explored by Western Blot Analysis, apoptosis assay, and caspase-3/7 activity analysis.</p> <p>Results</p> <p>Frequencies of methylated RASSF1A, CDH13, CACNA1A, HIN-1, and sFRP5 genes in OCCA tissues were significantly higher than those in non-OCCA cancerous tissues and benign endometriotic cysts<b>.</b> The expected OS for patients with methylated promoters of HIN-1 was significantly worse than those for patients without methylated HIN-1 (30% vs. 62%, <it>p</it> = 0.002). The HIN-1 gene was over-expressed in ES2 cells, a significant reduction in cell growth and induction of apoptosis, and increasing paclitaxel sensitivity by reducing phosphorylation of Akt were observed.</p> <p>Conclusions</p> <p>Methylation of HIN-1 promoter is a novel epigenetic biomarker associated with poor outcomes in OCCA patients. Ectopic expression of the HIN-1 gene increased paclitaxel sensitivity which is partly through Akt pathway.</p>
topic Ovarian clear cell adenocarcinoma
Methylation-specific multiplex ligation-dependent probe amplification
HIN-1
CACNA1A
url http://www.molecular-cancer.com/content/11/1/53
work_keys_str_mv AT hochihming promotermethylationstatusofhin1associatedwithoutcomesofovarianclearcelladenocarcinoma
AT huangchijung promotermethylationstatusofhin1associatedwithoutcomesofovarianclearcelladenocarcinoma
AT huangchiayen promotermethylationstatusofhin1associatedwithoutcomesofovarianclearcelladenocarcinoma
AT wuyihyiing promotermethylationstatusofhin1associatedwithoutcomesofovarianclearcelladenocarcinoma
AT changshwufen promotermethylationstatusofhin1associatedwithoutcomesofovarianclearcelladenocarcinoma
AT chengwenfang promotermethylationstatusofhin1associatedwithoutcomesofovarianclearcelladenocarcinoma
_version_ 1725284053697953792